{"id":"https://openalex.org/W1552913589","doi":"https://doi.org/10.1111/jphp.12080","title":"Prostaglandin E1-containing nanoparticles improve walking activity in an experimental rat model of intermittent claudication","display_name":"Prostaglandin E1-containing nanoparticles improve walking activity in an experimental rat model of intermittent claudication","publication_year":2013,"publication_date":"2013-05-21","ids":{"openalex":"https://openalex.org/W1552913589","doi":"https://doi.org/10.1111/jphp.12080","mag":"1552913589","pmid":"https://pubmed.ncbi.nlm.nih.gov/23837586"},"language":"en","primary_location":{"id":"doi:10.1111/jphp.12080","doi":"https://doi.org/10.1111/jphp.12080","is_oa":false,"landing_page_url":"https://doi.org/10.1111/jphp.12080","pdf_url":null,"source":{"id":"https://openalex.org/S118304455","display_name":"Journal of Pharmacy and Pharmacology","issn_l":"0022-3573","issn":["0022-3573","2042-7158"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy and Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102912043","display_name":"Tomoaki Ishihara","orcid":"https://orcid.org/0000-0001-6866-7547","observed_orcids":["https://orcid.org/0000-0001-6866-7547"]},"institutions":[{"id":"https://openalex.org/I104946051","display_name":"Nihon University","ror":"https://ror.org/05jk51a88","country_code":"JP","type":"education","lineage":["https://openalex.org/I104946051"]},{"id":"https://openalex.org/I203951103","display_name":"Keio University","ror":"https://ror.org/02kn6nx58","country_code":"JP","type":"education","lineage":["https://openalex.org/I203951103"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomoaki Ishihara","raw_affiliation_strings":["Department of Chemical Biology and Applied Chemistry, College of Engineering, Nihon University, Fukushima, Japan","Faculty of Pharmacy, Keio University, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemical Biology and Applied Chemistry, College of Engineering, Nihon University, Fukushima, Japan","institution_ids":["https://openalex.org/I104946051"]},{"raw_affiliation_string":"Faculty of Pharmacy, Keio University, Tokyo, Japan","institution_ids":["https://openalex.org/I203951103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018175007","display_name":"Yasunobu Yamashita","orcid":"https://orcid.org/0000-0001-5078-5940","observed_orcids":["https://orcid.org/0000-0001-5078-5940"]},"institutions":[{"id":"https://openalex.org/I203951103","display_name":"Keio University","ror":"https://ror.org/02kn6nx58","country_code":"JP","type":"education","lineage":["https://openalex.org/I203951103"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasunobu Yamashita","raw_affiliation_strings":["Faculty of Pharmacy, Keio University, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmacy, Keio University, Tokyo, Japan","institution_ids":["https://openalex.org/I203951103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050787264","display_name":"Naoko Takasaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I96036126","display_name":"Kumamoto University","ror":"https://ror.org/02cgss904","country_code":"JP","type":"education","lineage":["https://openalex.org/I96036126"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Naoko Takasaki","raw_affiliation_strings":["Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan","institution_ids":["https://openalex.org/I96036126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022772124","display_name":"Shuhei Yamamoto","orcid":"https://orcid.org/0000-0003-0257-633X","observed_orcids":["https://orcid.org/0000-0003-0257-633X","https://orcid.org/0009-0004-7783-2486"]},"institutions":[{"id":"https://openalex.org/I96036126","display_name":"Kumamoto University","ror":"https://ror.org/02cgss904","country_code":"JP","type":"education","lineage":["https://openalex.org/I96036126"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shuhei Yamamoto","raw_affiliation_strings":["Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan","institution_ids":["https://openalex.org/I96036126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008654102","display_name":"Erika Hayashi","orcid":"https://orcid.org/0000-0002-4507-1705","observed_orcids":["https://orcid.org/0000-0002-4507-1705"]},"institutions":[{"id":"https://openalex.org/I203951103","display_name":"Keio University","ror":"https://ror.org/02kn6nx58","country_code":"JP","type":"education","lineage":["https://openalex.org/I203951103"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Erika Hayashi","raw_affiliation_strings":["Faculty of Pharmacy, Keio University, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmacy, Keio University, Tokyo, Japan","institution_ids":["https://openalex.org/I203951103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015625327","display_name":"Kayoko Tahara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I163793406","display_name":"Health Sciences University of Hokkaido","ror":"https://ror.org/04tqcn816","country_code":"JP","type":"education","lineage":["https://openalex.org/I163793406"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kayoko Tahara","raw_affiliation_strings":["Faculty of Pharmacy, Health Sciences University of Hokkaido, Hokkaido, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmacy, Health Sciences University of Hokkaido, Hokkaido, Japan","institution_ids":["https://openalex.org/I163793406"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051583053","display_name":"Mitsuko Takenaga","orcid":"https://orcid.org/0000-0002-0165-8352","observed_orcids":["https://orcid.org/0000-0002-0165-8352"]},"institutions":[{"id":"https://openalex.org/I163917720","display_name":"St. Marianna University School of Medicine","ror":"https://ror.org/043axf581","country_code":"JP","type":"education","lineage":["https://openalex.org/I163917720"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mitsuko Takenaga","raw_affiliation_strings":["Division of Drug Delivery System, Institute of Medical Science, St. Marianna University, Kawasaki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Drug Delivery System, Institute of Medical Science, St. Marianna University, Kawasaki, Japan","institution_ids":["https://openalex.org/I163917720"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072425096","display_name":"Naoki Yamakawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I203951103","display_name":"Keio University","ror":"https://ror.org/02kn6nx58","country_code":"JP","type":"education","lineage":["https://openalex.org/I203951103"]},{"id":"https://openalex.org/I96036126","display_name":"Kumamoto University","ror":"https://ror.org/02cgss904","country_code":"JP","type":"education","lineage":["https://openalex.org/I96036126"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Naoki Yamakawa","raw_affiliation_strings":["Faculty of Pharmacy, Keio University, Tokyo, Japan","Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmacy, Keio University, Tokyo, Japan","institution_ids":["https://openalex.org/I203951103"]},{"raw_affiliation_string":"Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan","institution_ids":["https://openalex.org/I96036126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016137949","display_name":"Tsutomu Ishihara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I104946051","display_name":"Nihon University","ror":"https://ror.org/05jk51a88","country_code":"JP","type":"education","lineage":["https://openalex.org/I104946051"]},{"id":"https://openalex.org/I203951103","display_name":"Keio University","ror":"https://ror.org/02kn6nx58","country_code":"JP","type":"education","lineage":["https://openalex.org/I203951103"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tsutomu Ishihara","raw_affiliation_strings":["Department of Chemical Biology and Applied Chemistry, College of Engineering, Nihon University, Fukushima, Japan","Faculty of Pharmacy, Keio University, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemical Biology and Applied Chemistry, College of Engineering, Nihon University, Fukushima, Japan","institution_ids":["https://openalex.org/I104946051"]},{"raw_affiliation_string":"Faculty of Pharmacy, Keio University, Tokyo, Japan","institution_ids":["https://openalex.org/I203951103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101777381","display_name":"Tadashi Kasahara","orcid":"https://orcid.org/0000-0001-7687-5477","observed_orcids":["https://orcid.org/0000-0001-7687-5477"]},"institutions":[{"id":"https://openalex.org/I203951103","display_name":"Keio University","ror":"https://ror.org/02kn6nx58","country_code":"JP","type":"education","lineage":["https://openalex.org/I203951103"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tadashi Kasahara","raw_affiliation_strings":["Faculty of Pharmacy, Keio University, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmacy, Keio University, Tokyo, Japan","institution_ids":["https://openalex.org/I203951103"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108542604","display_name":"Tohru Mizushima","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I203951103","display_name":"Keio University","ror":"https://ror.org/02kn6nx58","country_code":"JP","type":"education","lineage":["https://openalex.org/I203951103"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Tohru Mizushima","raw_affiliation_strings":["Faculty of Pharmacy, Keio University, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmacy, Keio University, Tokyo, Japan","institution_ids":["https://openalex.org/I203951103"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5108542604"],"corresponding_institution_ids":["https://openalex.org/I203951103"],"apc_list":{"value":2911,"currency":"GBP","value_usd":3839},"apc_paid":null,"fwci":0.2247,"has_fulltext":true,"cited_by_count":6,"citation_normalized_percentile":{"value":0.44942421,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"65","issue":"8","first_page":"1187","last_page":"1194"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.6279000043869019,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.6279000043869019,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10926","display_name":"Peripheral Artery Disease Management","score":0.2842000126838684,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.010900000110268593,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prostaglandin-e1","display_name":"prostaglandin E1","score":1.0},{"id":"https://openalex.org/keywords/nanoparticles","display_name":"nanoparticles","score":0.8759999871253967},{"id":"https://openalex.org/keywords/intermittent-claudication","display_name":"intermittent claudication","score":0.8849999904632568},{"id":"https://openalex.org/keywords/femoral-artery-ligation","display_name":"femoral artery ligation","score":0.9679999947547913},{"id":"https://openalex.org/keywords/sustained-release","display_name":"sustained drug release","score":0.5920000076293945},{"id":"https://openalex.org/keywords/lipid-emulsions","display_name":"lipid emulsions","score":0.7480000257492065},{"id":"https://openalex.org/keywords/skeletal-muscle-angiogenesis","display_name":"skeletal muscle angiogenesis","score":0.8820000290870667},{"id":"https://openalex.org/keywords/walking-activity","display_name":"walking activity","score":0.6930000185966492},{"id":"https://openalex.org/keywords/tissue-accumulation","display_name":"tissue accumulation","score":0.4860000014305115},{"id":"https://openalex.org/keywords/peripheral-arterial-disease","display_name":"peripheral arterial disease","score":0.7139999866485596}],"concepts":[{"id":"https://openalex.org/C2779837120","wikidata":"https://www.wikidata.org/wiki/Q579348","display_name":"Prostaglandin E1","level":2,"score":0.7807937860488892},{"id":"https://openalex.org/C2779881954","wikidata":"https://www.wikidata.org/wiki/Q1097957","display_name":"Intermittent claudication","level":4,"score":0.6393352746963501},{"id":"https://openalex.org/C179437574","wikidata":"https://www.wikidata.org/wiki/Q15089798","display_name":"Ligation","level":2,"score":0.6311576962471008},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5988193154335022},{"id":"https://openalex.org/C2779723990","wikidata":"https://www.wikidata.org/wiki/Q707174","display_name":"Femoral artery","level":2,"score":0.5418859124183655},{"id":"https://openalex.org/C2781156865","wikidata":"https://www.wikidata.org/wiki/Q827023","display_name":"Lesion","level":2,"score":0.5080499649047852},{"id":"https://openalex.org/C2779959927","wikidata":"https://www.wikidata.org/wiki/Q1048687","display_name":"Skeletal muscle","level":2,"score":0.4823295772075653},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.45615875720977783},{"id":"https://openalex.org/C25938499","wikidata":"https://www.wikidata.org/wiki/Q7663812","display_name":"Systemic administration","level":3,"score":0.4157756268978119},{"id":"https://openalex.org/C2780664492","wikidata":"https://www.wikidata.org/wiki/Q209717","display_name":"Prostaglandin","level":2,"score":0.4117588996887207},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37770766019821167},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3764348328113556},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.34585508704185486},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3023874759674072},{"id":"https://openalex.org/C2777466421","wikidata":"https://www.wikidata.org/wiki/Q1266890","display_name":"Vascular disease","level":2,"score":0.18275049328804016},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.17985287308692932},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.12194618582725525},{"id":"https://openalex.org/C3018348675","wikidata":"https://www.wikidata.org/wiki/Q4797557","display_name":"Arterial disease","level":3,"score":0.07576847076416016},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000527","descriptor_name":"Alprostadil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000527","descriptor_name":"Alprostadil","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000527","descriptor_name":"Alprostadil","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002196","descriptor_name":"Capillaries","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002196","descriptor_name":"Capillaries","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002196","descriptor_name":"Capillaries","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005080","descriptor_name":"Exercise Test","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005263","descriptor_name":"Femoral Artery","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005263","descriptor_name":"Femoral Artery","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005263","descriptor_name":"Femoral Artery","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D007383","descriptor_name":"Intermittent Claudication","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007383","descriptor_name":"Intermittent Claudication","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D010316","descriptor_name":"Particle Size","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014665","descriptor_name":"Vasodilator Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014665","descriptor_name":"Vasodilator Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D014665","descriptor_name":"Vasodilator Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016138","descriptor_name":"Walking","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018919","descriptor_name":"Neovascularization, Physiologic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D035002","descriptor_name":"Lower Extremity","qualifier_ui":"Q000098","qualifier_name":"blood supply","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/jphp.12080","doi":"https://doi.org/10.1111/jphp.12080","is_oa":false,"landing_page_url":"https://doi.org/10.1111/jphp.12080","pdf_url":null,"source":{"id":"https://openalex.org/S118304455","display_name":"Journal of Pharmacy and Pharmacology","issn_l":"0022-3573","issn":["0022-3573","2042-7158"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy and Pharmacology","raw_type":"journal-article"},{"id":"pmid:23837586","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23837586","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of pharmacy and pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320320912","display_name":"Ministry of Education, Culture, Sports, Science and Technology","ror":"https://ror.org/048rj2z13"},{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"},{"id":"https://openalex.org/F4320334789","display_name":"Japan Science and Technology Agency","ror":"https://ror.org/00097mb19"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W266691892","https://openalex.org/W1654518922","https://openalex.org/W1973793029","https://openalex.org/W1983755918","https://openalex.org/W1983969834","https://openalex.org/W1984290024","https://openalex.org/W1988127477","https://openalex.org/W1988944787","https://openalex.org/W2001564111","https://openalex.org/W2002283652","https://openalex.org/W2002516695","https://openalex.org/W2007876234","https://openalex.org/W2011748786","https://openalex.org/W2015312408","https://openalex.org/W2026758996","https://openalex.org/W2029749273","https://openalex.org/W2037636695","https://openalex.org/W2045516308","https://openalex.org/W2047375798","https://openalex.org/W2053784946","https://openalex.org/W2058102497","https://openalex.org/W2069793694","https://openalex.org/W2087092191","https://openalex.org/W2089538662","https://openalex.org/W2090990359","https://openalex.org/W2119010376","https://openalex.org/W2139288452","https://openalex.org/W2144985796","https://openalex.org/W2146382400","https://openalex.org/W2414286666","https://openalex.org/W2427012143","https://openalex.org/W4240123733"],"related_works":["https://openalex.org/W1995299799","https://openalex.org/W2402318622","https://openalex.org/W2067073316","https://openalex.org/W2037636695","https://openalex.org/W1998136977","https://openalex.org/W2606627670","https://openalex.org/W2273633767","https://openalex.org/W1996903600","https://openalex.org/W1969199672","https://openalex.org/W950755514"],"abstract_inverted_index":{"OBJECTIVES:":[0],"Due":[1],"to":[2,53],"the":[3,42,59,82,117,123,139,154,182,186,199,207],"low":[4],"stability":[5],"of":[6,12,39,62,69,81,92,126,130,136,166,170,176,192,202,212],"lipid":[7,10],"emulsions,":[8],"a":[9,35,49,65,87,163],"emulsion":[11],"prostaglandin":[13],"E1":[14],"(Lipo-PGE1":[15],")":[16],"necessitates":[17],"daily":[18],"intravenous":[19,124],"drip":[20],"infusions.":[21],"To":[22],"overcome":[23],"this":[24,193],"issue,":[25],"we":[26],"developed":[27],"nanoparticles":[28,43],"containing":[29],"PGE1":[30,40,93,112,213],"(Nano-PGE1":[31],").":[32],"Nano-PGE1":[33,63,127,137,167,177,197],"showed":[34],"good":[36],"sustained-release":[37],"profile":[38],"from":[41],"in":[44,64,116,138,158,181],"vitro,":[45],"which":[46,157],"may":[47],"permit":[48],"longer-lasting":[50],"therapeutic":[51],"effect":[52],"be":[54,114],"achieved.":[55],"We":[56],"here":[57],"examined":[58],"pharmacological":[60],"activity":[61,80,201],"rat":[66,83],"experimental":[67],"model":[68],"intermittent":[70],"claudication":[71],"induced":[72],"by":[73,96,107,162],"femoral":[74,203],"artery":[75],"ligation.":[76],"METHODS:":[77],"The":[78,150,173,190],"walking":[79,155,200],"was":[84,105,147,160],"tested":[85],"on":[86],"rodent":[88],"treadmill.":[89],"Tissue":[90],"levels":[91],"were":[94],"determined":[95],"enzyme":[97],"immunoassay,":[98],"and":[99,209],"skeletal":[100,183],"muscle":[101,184],"angiogenesis":[102,180],"(capillary":[103],"growth)":[104],"monitored":[106],"immunohistochemical":[108],"analysis.":[109],"KEY":[110],"FINDINGS:":[111],"could":[113],"detected":[115],"lesion":[118,140],"site":[119,141,146],"one":[120],"day":[121],"after":[122],"administration":[125,165,175],"but":[128,168],"not":[129,169],"Lipo-PGE1":[131,171],".":[132,172,214],"An":[133],"increased":[134],"accumulation":[135,208],"compared":[142],"with":[143],"control":[144],"(unlesioned)":[145],"also":[148,178],"observed.":[149],"ligation":[151],"procedure":[152],"reduced":[153],"activity,":[156],"turn":[159],"improved":[161],"single":[164,174],"stimulated":[179],"around":[185],"ligated":[187],"artery.":[188],"CONCLUSIONS:":[189],"findings":[191],"study":[194],"suggest":[195],"that":[196],"improves":[198],"artery-ligated":[204],"rats":[205],"through":[206],"sustained":[210],"release":[211]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}
